Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410365 | SCV000487132 | likely pathogenic | Tyrosinemia type I | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000410365 | SCV004468784 | pathogenic | Tyrosinemia type I | 2023-12-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro5Argfs*28) in the FAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FAH-related conditions. ClinVar contains an entry for this variant (Variation ID: 371526). For these reasons, this variant has been classified as Pathogenic. |